186 related articles for article (PubMed ID: 11253161)
21. Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia.
Castaño G; Más R; Fernández JC; Fernández L; Illnait J; López E
Drugs R D; 2002; 3(3):159-72. PubMed ID: 12099160
[TBL] [Abstract][Full Text] [Related]
22. [A randomized, double-blind, placebo-controlled study of the antilipemic efficacy and tolerability of food supplement policosanol in patients with moderate hypercholesterolemia].
Tedeschi-Reiner E; Reiner Z; Romić Z; Ivanković D
Lijec Vjesn; 2005; 127(11-12):273-9. PubMed ID: 16583932
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials.
Gong J; Qin X; Yuan F; Hu M; Chen G; Fang K; Wang D; Jiang S; Li J; Zhao Y; Huang Z; Dong H; Lu F
Mol Nutr Food Res; 2018 Jan; 62(1):. PubMed ID: 28730734
[TBL] [Abstract][Full Text] [Related]
24. A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia.
Canetti M; Moreira M; Mas R; Illnait J; Fernandez L; Fernandez J; Diaz E; Castano G
Int J Clin Pharmacol Res; 1995; 15(4):159-65. PubMed ID: 8871266
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of policosanol Versus acipimox in patients with type II hypercholesterolemia.
Alcocer L; Fernández L; Campos E; Más R
Int J Tissue React; 1999; 21(3):85-92. PubMed ID: 10645516
[TBL] [Abstract][Full Text] [Related]
26. [Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia].
Prat H; Román O; Pino E
Rev Med Chil; 1999 Mar; 127(3):286-94. PubMed ID: 10436712
[TBL] [Abstract][Full Text] [Related]
27. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.
Gouni-Berthold I; Berthold HK
Am Heart J; 2002 Feb; 143(2):356-65. PubMed ID: 11835043
[TBL] [Abstract][Full Text] [Related]
28. Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia.
Francini-Pesenti F; Beltramolli D; Dall'acqua S; Brocadello F
Phytother Res; 2008 Mar; 22(3):318-22. PubMed ID: 18167048
[TBL] [Abstract][Full Text] [Related]
29. [EFFICIENCY OF CONCOMITANT USE OF POLICOSANOL AND ROSUVASTATIN IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE AND MODERATE HEPATIC DYSFUNCTION].
Solomenchuk TM; Vosukh V; Bedzay A; Koval VG; Chepka IM; Trotsko VV
Lik Sprava; 2015; (7-8):29-37. PubMed ID: 27491147
[TBL] [Abstract][Full Text] [Related]
30. Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia: a double blind, controlled study.
Francini-Pesenti F; Brocadello F; Beltramolli D; Nardi M; Caregaro L
Complement Ther Med; 2008 Apr; 16(2):61-5. PubMed ID: 18514906
[TBL] [Abstract][Full Text] [Related]
31. Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations.
Lin Y; Rudrum M; van der Wielen RP; Trautwein EA; McNeill G; Sierksma A; Meijer GW
Metabolism; 2004 Oct; 53(10):1309-14. PubMed ID: 15375787
[TBL] [Abstract][Full Text] [Related]
32. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
[TBL] [Abstract][Full Text] [Related]
33. Lack of cholesterol-lowering efficacy of Cuban sugar cane policosanols in hypercholesterolemic persons.
Kassis AN; Jones PJ
Am J Clin Nutr; 2006 Nov; 84(5):1003-8. PubMed ID: 17093150
[TBL] [Abstract][Full Text] [Related]
34. Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study.
Castaño G; Más R; Gámez R; Fernández L; Illnait J
Angiology; 2004; 55(4):361-71. PubMed ID: 15258682
[TBL] [Abstract][Full Text] [Related]
35. Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study.
Castaño G; Más R; Fernández J; López E; Illnait J; Fernández L; Mesa M
Curr Ther Res Clin Exp; 2003 Sep; 64(8):522-37. PubMed ID: 24944402
[TBL] [Abstract][Full Text] [Related]
36. [Long-term effect of policosanol on the functional recovery of non-cardioembolic ischemic stroke patients: a one year study].
Sanchez J; Illnait J; Mas R; Mendoza S; Fernandez L; Mesa M; Vega H; Fernandez J; Reyes P; Ruiz D
Rev Neurol; 2017 Feb; 64(4):153-161. PubMed ID: 28169410
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol.
Chen JT; Wesley R; Shamburek RD; Pucino F; Csako G
Pharmacotherapy; 2005 Feb; 25(2):171-83. PubMed ID: 15767233
[TBL] [Abstract][Full Text] [Related]
38. Policosanol Attenuates Cholesterol Synthesis via AMPK Activation in Hypercholesterolemic Rats.
Nam DE; Yun JM; Kim D; Kim OK
J Med Food; 2019 Nov; 22(11):1110-1117. PubMed ID: 31613687
[TBL] [Abstract][Full Text] [Related]
39. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
Marazzi G; Cacciotti L; Pelliccia F; Iaia L; Volterrani M; Caminiti G; Sposato B; Massaro R; Grieco F; Rosano G
Adv Ther; 2011 Dec; 28(12):1105-13. PubMed ID: 22113535
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
